Price data is not available
ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD (TYPTF) Stock Price, Quote, News & History
TYPTFOTCPK
Tryptamine Therapeutics advances TRP-8803, an IV psilocin therapy with rapid onset and enhanced safety, to Phase 2 clinical trials.
You can purchase shares of ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD (OTCPK:TYPTF) through any online brokerage.
There are no as such competitors for ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD.
There is no analysis for ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD to provide a consensus price target.
The stock price for ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD (OTCPK: TYPTF) is $0.0202 last updated November 10, 2026 at 1:34 PM EST.
There are no upcoming dividends for ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD.
ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD does not have any upcoming earnings scheduled.
There is no upcoming split for ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD.
ENTROPY NEURODYNAMICS LTD by ENTROPY NEURODYNAMICS LTD is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.
Entropy Neurodynamics Ltd is in biopharmaceutical drug development. The group has only operated in one Segment, being research and development of biopharmaceutical drugs.
